Publication Name	World Journal of Orthopedics
Manuscript ID	64688
Country	Japan

Category	Orthopedics
Manuscript Type	Minireviews
Article Title	Effects of sclerostin antibody on bone healing
Manuscript Source	Invited Manuscript
All Author List	Atsushi Mihara, Kiminori Yukata, Toshihiro Seki, Ryuta Iwanaga, Norihiro Nishida, Kenzo Fujii, Yuji Nagao and Takashi Sakai
Funding Agency and Grant Number
Corresponding Author	Kiminori Yukata, MD, PhD, Associate Professor, Department of Orthopedic Surgery, Yamaguchi University Graduate School of Medicine, 1-1-1 Minami-Kogushi, Ube 755-8505, Japan. kyukata2004jp@yahoo.co.jp
Key Words	Canonical Wnt-β-catenin pathway; Fracture healing; Osteoporosis; Romosozumab; Sclerostin antibody
Core Tip	Sclerostin antibody (Scl-Ab) has been recently introduced for the treatment of osteoporosis. Several researchers have reported on the effects of Scl-Ab in bone fracture healing because of its rich osteogenic potential. In this review, we describe the latest reports of preclinical and clinical studies on the bone-healing effects of Scl-Ab.
Citation	Mihara A, Yukata K, Seki T, Iwanaga R, Nishida N, Fujii K, Nagao Y, Sakai T. Effects of sclerostin antibody on bone healing. World J Orthop 2021; 12(9): 651-659

Received	2021-03-08 09:33
Peer-Review Started	2021-03-08 09:36
To Make the First Decision
Return for Revision	2021-03-31 00:45
Revised	2021-04-12 12:49
Second Decision	2021-08-04 03:34
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2021-08-04 08:04
Articles in Press	2021-08-04 08:04
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2021-09-05 14:58

ISSN	2218-5836 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com